| Bimetallic nanowires as electrocatalysts for nonenzymatic real-time impedancimetric detection of glucose. | |
| | |
MedLine Citation:
|
PMID: 22183014 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Gold-platinum nanowires are proposed as electrocatalysts for a real-time nonenzymatic impedancimetric detection of glucose. The electrochemical behavior of the obtained platform toward electrocatalytic oxidation of glucose, including a proposal for the detection mechanism, is shown. |
| | |
Authors:
|
Carmen C Mayorga-Martinez; Maria Guix; Rossana E Madrid; Arben Merkoçi |
Related Documents
:
|
1609264 - Neutrophil count and activation in vascular disease. 11872364 - Influence of insulin and of insulin resistance on platelet and vascular smooth muscle c... 10418854 - Insulin signaling in the arterial wall. 11738074 - Separation and characterization of the molecular species of thrombomodulin in the plasm... 18955324 - Effects of satureja khuzestanica on serum glucose, lipids and markers of oxidative stre... 8495594 - Diabetes mellitus secondary to chronic pancreatitis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-19 |
Journal Detail:
|
Title: Chemical communications (Cambridge, England) Volume: - ISSN: 1364-548X ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9610838 Medline TA: Chem Commun (Camb) Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Nanobioelectronics & Biosensors Group, Catalan Institute of Nanotechnology, Campus UAB, 08193 Bellaterra, Barcelona, Catalonia, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Assessment of Changes in Cognitive Functioning: Age-, Education-, and Gender-Specific Reliable ...
Next Document: PET/CT using 18F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.